Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding ...

Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a ...

The One Big Beautiful Bill Act introduced a new $50 billion fund to offer rural hospitals a financial lifeline. One expert ...

Stem cell transplants that are a standard treatment for certain blood cancers are out of reach for many patients. The procedure requires cells from a matched donor, but a match isn’t always available.

Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person's risk of heart attack, we can intervene earlier and more effectively.

A judge has approved Blue Cross Blue Shield's $2.8 billion settlement with providers. However, some providers are opting out, arguing that it doesn't go far enough.

August has seen a slew of executive hires, exits and layoffs across the healthcare sector. For example, OpenAI, Veradigm and Qure.ai welcomed new executives. There were also layoffs at ...

Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost ...

EVERSANA, a pharma commercialization company, and Waltz Health, a digital prescription drug company, are merging into a $6 billion entity, they announced on Tuesday.

Boston-based startup Cascala Health raised an $8.6 million seed round to expand its AI platform for risk-bearing providers. The platform is designed to make patient care transitions safer and more ...